Galectin Therapeutics Inc...

NASDAQ: GALT · Real-Time Price · USD
3.57
-0.19 (-5.05%)
At close: Aug 15, 2025, 3:59 PM
3.55
-0.56%
After-hours: Aug 15, 2025, 06:50 PM EDT

Galectin Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-47.05M -41.07M -38.78M -30.53M
Depreciation & Amortization
37K 33K 32K 41K
Stock-Based Compensation
2.45M 2.26M 2.87M 2.08M
Other Working Capital
4.36M 2.01M 724K 65K
Other Non-Cash Items
512K 1.13M -147K 351K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.28M 4.68M 4.97M 3.75M
Operating Cash Flow
-41.77M -32.97M -31.06M -24.31M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
30M 30M 10M 30M
Common Stock Repurchased
845K 671K 899K n/a
Dividend Paid
-91K n/a -97K -171K
Other Financial Acitivies
1.23M 10.03M 97K 171K
Financial Cash Flow
31.23M 40.03M 10M 36.81M
Net Cash Flow
-10.54M 7.07M -21.06M 12.51M
Free Cash Flow
-41.77M -32.97M -31.06M -24.31M